Načítá se...
Fine-tuning anti-tumor immunotherapies via stochastic simulations
BACKGROUND: Anti-tumor therapies aim at reducing to zero the number of tumor cells in a host within their end or, at least, aim at leaving the patient with a sufficiently small number of tumor cells so that the residual tumor can be eradicated by the immune system. Besides severe side-effects, a key...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3303725/ https://ncbi.nlm.nih.gov/pubmed/22536975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2105-13-S4-S8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|